Open tender · Germany · Contract notice
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Sapropterin (ausschließlich Darreichungsform PLE), ATC A16AX07 für die Zeit 01.07.2025 - 30.06.2027
DAK-Gesundheit in Germany is inviting bids for “Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Sapropterin (ausschließlich Darreichungsform PLE), ATC…”. Bids close on 5 May 2027. To qualify, bidders need at least one similar completed work.
The work
Conclusion of a non-exclusive discount agreement for the active substance Sapropterin (form PLE) for the period 01.07.2025 - 30.06.2027.
- Agreement form available at www.dtvp.de/center
- Submission of specific documents (Angebotsschreiben, Anlage 1, Anlage 2) via email
Key facts
- Contract period
- 01.07.2025 - 30.06.2027
- Evaluation
- Lowest price (L1) among technically qualified bids
- Submission
- Online, on the e-procurement portal
What it takes to qualify
Worth a closer look
- The document is a German tender, not an Indian government tender, so standard Indian compliance items like GST, PAN, etc., are not applicable.
- The selection criteria are listed as 'Siehe Antragsschreiben', which is not provided.
Experience
- At least 1 similar work — Not specified in the provided text.
- Not specified in the provided text.
Certifications and registrations
GST registration (optional)Not mentioned in the provided text.
PAN registration (optional)Not mentioned in the provided text.
EPF registration (optional)Not mentioned in the provided text.
ESIC registration (optional)Not mentioned in the provided text.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- AngebotsschreibenSubmission via email to openhouse@dak.de.
- Anerkennung der vertraglichen Maßgaben der DAK-GesundheitSubmission via email to openhouse@dak.de.
- Anlage 1 zum VertragSubmission via email to openhouse@dak.de.
- Anlage 2 zum VertragSubmission via email to openhouse@dak.de as an Excel file.